STRO - Sutro Biopharma, Inc.

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
0.81 -0.03 (-3.7%)	---	---	-0.02 (-1.96%)	-0.01 (-1.21%)	-0.02 (-2.78%)	-0.02 (-2.38%)	-0.02 (-2.38%)

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

Market Period: Closed

Earnings & Ratios

Basic EPS:: -0.14
Diluted EPS:: -0.14
Basic P/E:: -5.5714
Diluted P/E:: -5.5714
RSI(14) 1m:: 5.88
VWAP:: 0.78
RVol:: 1.822

Events

Period	Kind	Movement	Occurred At
1m	Price decrease 1m	0.78 -0.01 (-1.29%)	Oct 15 19:10
1m	Price increase 1m	0.8 +0.01 (+1.01%)	Oct 15 12:03
1m	Price increase 1m	0.8 +0.01 (+1.02%)	Oct 15 09:59
1m	Price decrease 1m	0.8 -0.01 (-1.21%)	Oct 15 09:29